These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 26660233
21. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ, Lenhard SC, Haimbach RE, Schaeffer TR, Bentley RG, McVey MJ, Chandra S, Irving EA, Andrew A Parsons, Barone FC. Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [Abstract] [Full Text] [Related]
22. Acidic fibroblast growth factor delivered intranasally induces neurogenesis and angiogenesis in rats after ischemic stroke. Cheng X, Wang Z, Yang J, Ma M, Lu T, Xu G, Liu X. Neurol Res; 2011 Sep; 33(7):675-80. PubMed ID: 21756545 [Abstract] [Full Text] [Related]
23. CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke. Gutiérrez-Fernández M, Rodríguez-Frutos B, Fuentes B, Vallejo-Cremades MT, Alvarez-Grech J, Expósito-Alcaide M, Díez-Tejedor E. Neurochem Int; 2012 Feb; 60(3):310-7. PubMed ID: 22226841 [Abstract] [Full Text] [Related]
24. Continuous administration of a p38α inhibitor during the subacute phase after transient ischemia-induced stroke in the rat promotes dose-dependent functional recovery accompanied by increase in brain BDNF protein level. Alam JJ, Krakovsky M, Germann U, Levy A. PLoS One; 2020 Feb; 15(12):e0233073. PubMed ID: 33275615 [Abstract] [Full Text] [Related]
26. Neuroprotection of early and short-time applying berberine in the acute phase of cerebral ischemia: up-regulated pAkt, pGSK and pCREB, down-regulated NF-κB expression, ameliorated BBB permeability. Zhang X, Zhang X, Wang C, Li Y, Dong L, Cui L, Wang L, Liu Z, Qiao H, Zhu C, Xing Y, Cao X, Ji Y, Zhao K. Brain Res; 2012 Jun 12; 1459():61-70. PubMed ID: 22560097 [Abstract] [Full Text] [Related]
27. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Zhang L, Zhang ZG, Zhang R, Morris D, Lu M, Coller BS, Chopp M. Circulation; 2003 Jun 10; 107(22):2837-43. PubMed ID: 12756151 [Abstract] [Full Text] [Related]
28. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial. Culman J, Nguyen-Ngoc M, Glatz T, Gohlke P, Herdegen T, Zhao Y. Exp Neurol; 2012 Dec 10; 238(2):243-53. PubMed ID: 22995601 [Abstract] [Full Text] [Related]
29. A comparison of long-term functional outcome after 2 middle cerebral artery occlusion models in rats. Roof RL, Schielke GP, Ren X, Hall ED. Stroke; 2001 Nov 10; 32(11):2648-57. PubMed ID: 11692030 [Abstract] [Full Text] [Related]
30. Differential effect of the alpha2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke. Butovas S, Lukkarinen J, Virtanen T, Jolkkonen J, Sivenius J. Restor Neurol Neurosci; 2001 Nov 10; 18(4):143-51. PubMed ID: 11847437 [Abstract] [Full Text] [Related]
31. Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery. Hawkins KE, DeMars KM, Alexander JC, de Leon LG, Pacheco SC, Graves C, Yang C, McCrea AO, Frankowski JC, Garrett TJ, Febo M, Candelario-Jalil E. Brain Behav; 2017 May 10; 7(5):e00688. PubMed ID: 28523230 [Abstract] [Full Text] [Related]
32. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia. Yang C, Zhang X, Fan H, Liu Y. Brain Res; 2009 Jul 28; 1282():133-41. PubMed ID: 19445907 [Abstract] [Full Text] [Related]
33. Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part II: suppression of astrocytic activation by a novel agent (R)-(-)-2-propyloctanoic acid (ONO-2506) leads to mitigation of delayed infarct expansion and early improvement of neurologic deficits. Tateishi N, Mori T, Kagamiishi Y, Satoh S, Katsube N, Morikawa E, Morimoto T, Matsui T, Asano T. J Cereb Blood Flow Metab; 2002 Jun 28; 22(6):723-34. PubMed ID: 12045671 [Abstract] [Full Text] [Related]
34. Strategies to improve post-stroke behavioral recovery in aged subjects. Buga AM, Bălşeanu A, Popa-Wagner A, Mogoantă L. Rom J Morphol Embryol; 2009 Jun 28; 50(4):559-82. PubMed ID: 19942950 [Abstract] [Full Text] [Related]
35. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery. Yang Y, Salayandia VM, Thompson JF, Yang LY, Estrada EY, Yang Y. J Neuroinflammation; 2015 Feb 10; 12():26. PubMed ID: 25889169 [Abstract] [Full Text] [Related]
36. Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats. Ishrat T, Sayeed I, Atif F, Stein DG. Brain Res; 2009 Feb 27; 1257():94-101. PubMed ID: 19135987 [Abstract] [Full Text] [Related]
37. Therapeutic neuroprotective effects of XQ-1H in a rat model of permanent focal cerebral ischemia. Yang Q, Fang W, Lv P, Geng X, Li Y, Sha L. Pharmacology; 2012 Feb 27; 89(1-2):1-6. PubMed ID: 22178991 [Abstract] [Full Text] [Related]
38. Effect of large dose hyperbaric oxygenation therapy on prognosis and oxidative stress of acute permanent cerebral ischemic stroke in rats. Xue L, Yu Q, Zhang H, Liu Y, Wang C, Wang Y. Neurol Res; 2008 May 27; 30(4):389-93. PubMed ID: 18544257 [Abstract] [Full Text] [Related]
39. Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal. Gutiérrez-Fernández M, Fuentes B, Rodríguez-Frutos B, Ramos-Cejudo J, Otero-Ortega L, Díez-Tejedor E. J Neurosci Res; 2015 May 27; 93(5):806-14. PubMed ID: 25524827 [Abstract] [Full Text] [Related]
40. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats. Sato T, Takamori H, Shirasaki Y. Pharmacology; 2004 May 27; 71(1):38-45. PubMed ID: 15051921 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]